Status:
ACTIVE_NOT_RECRUITING
PILOT Phase: BPD Study
Lead Sponsor:
University of California, Los Angeles
Conditions:
Borderline Personality Disorder
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
This pilot study aims to identify the area of the brain best suited for the treatment of Borderline Personality disorder (BPD). The study investigators will test whether repetitiveTranscranial Magneti...
Detailed Description
Borderline personality disorder (BPD) is a serious neuropsychiatric illness with a prevalence of 1-5% in the general population. Two core symptoms of BPD are emotional dysregulation and increased impu...
Eligibility Criteria
Inclusion
- Age of 18-65
- DSM-5 Diagnosis of Borderline Personality Disorder (BPD) based upon a psychiatric evaluation and ZAN-BPD scale
- Fluent English speaker
- Ability to give informed consent
Exclusion
- Medical conditions that prevent TMS or MRI to be performed safely upon evaluation by the study psychiatrist
- Active alcohol or drug abuse of such severity that it would pose a risk for TMS administration (i.e., unstable motor thresholds or increased risk for seizure)
- Active suicidal plan
- Current diagnosis of Psychotic or Bipolar disorders
Key Trial Info
Start Date :
January 5 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT07223619
Start Date
January 5 2024
End Date
December 31 2025
Last Update
November 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Semel Institute/ UCLA TMS
Los Angeles, California, United States, 90024